Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation.

Although the prognostic relevance did not reach statistical significance in our cohort, most likely due to the limited sample size, future studies with larger patient numbers will help to clarify this effect.

also in 111,027 other papers